1. An alternative approach for the assessment of rate of absorption in bioequivalence studies;Chen;Pharm. Res.,1992
2. Variation of Cmax and Cmax/AUC in investigations of bioequivalence;Endrenyi;Int. J. Clin. Pharmacol. Ther. Toxicol.,1993
3. Cmax/AUC is a clearer measure than Cmax for absorption rates in investigations of bioequivalence;Endrenyi;Int. J. Clin. Pharmacol. Ther. Toxicol.,1991
4. The bioavailability protocol guideline for ANDA and NDA submission;Food and Drug Adminstration,1977
5. The two period change-over design and its use in clinical trials;Grizzle;Biometrics,1965